Tajinder P. Singh, M.B.,B.S., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Transplantation | 80 | 2024 | 3220 | 11.360 |
Why?
|
Heart-Lung Transplantation | 15 | 2023 | 87 | 4.140 |
Why?
|
Waiting Lists | 17 | 2015 | 762 | 3.660 |
Why?
|
Graft Rejection | 25 | 2024 | 4426 | 2.490 |
Why?
|
Graft Survival | 19 | 2024 | 3794 | 2.100 |
Why?
|
Cardiomyopathy, Dilated | 9 | 2015 | 818 | 1.550 |
Why?
|
Lung Transplantation | 9 | 2023 | 1305 | 1.540 |
Why?
|
Tissue Donors | 11 | 2024 | 2311 | 1.510 |
Why?
|
Registries | 26 | 2023 | 8175 | 1.460 |
Why?
|
Primary Graft Dysfunction | 3 | 2021 | 111 | 1.330 |
Why?
|
Societies, Medical | 15 | 2022 | 3891 | 1.310 |
Why?
|
Tissue and Organ Procurement | 9 | 2022 | 943 | 1.300 |
Why?
|
Organ Transplantation | 6 | 2023 | 1150 | 1.230 |
Why?
|
Heart Failure | 20 | 2020 | 11593 | 1.110 |
Why?
|
Infant | 52 | 2024 | 36055 | 0.950 |
Why?
|
Child | 73 | 2024 | 79818 | 0.920 |
Why?
|
Heart Diseases | 8 | 2022 | 2782 | 0.890 |
Why?
|
Social Class | 3 | 2024 | 1999 | 0.890 |
Why?
|
Echocardiography, Doppler | 3 | 2020 | 898 | 0.870 |
Why?
|
Antilymphocyte Serum | 3 | 2023 | 482 | 0.860 |
Why?
|
Hospital Mortality | 8 | 2019 | 5272 | 0.830 |
Why?
|
Risk Assessment | 21 | 2021 | 23884 | 0.800 |
Why?
|
Child, Preschool | 49 | 2024 | 42062 | 0.780 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2020 | 2115 | 0.780 |
Why?
|
Survival Rate | 22 | 2023 | 12721 | 0.750 |
Why?
|
Thoracic Surgery | 3 | 2021 | 722 | 0.730 |
Why?
|
Heart Rate | 7 | 2010 | 4166 | 0.710 |
Why?
|
Hospitals, Special | 1 | 2020 | 91 | 0.710 |
Why?
|
Adolescent | 60 | 2024 | 87892 | 0.710 |
Why?
|
Cardiomyopathies | 6 | 2015 | 1944 | 0.700 |
Why?
|
Heart Defects, Congenital | 12 | 2017 | 4673 | 0.690 |
Why?
|
Oxygen Consumption | 7 | 2013 | 1845 | 0.690 |
Why?
|
Immunosuppressive Agents | 7 | 2023 | 4158 | 0.680 |
Why?
|
Lung Diseases | 4 | 2021 | 1910 | 0.650 |
Why?
|
Retrospective Studies | 50 | 2024 | 80168 | 0.640 |
Why?
|
Heart | 10 | 2022 | 4382 | 0.630 |
Why?
|
Exercise Test | 11 | 2013 | 2121 | 0.620 |
Why?
|
Heart-Assist Devices | 8 | 2019 | 1279 | 0.590 |
Why?
|
Donor Selection | 4 | 2019 | 227 | 0.580 |
Why?
|
Heart Ventricles | 5 | 2013 | 3806 | 0.580 |
Why?
|
Physical Exertion | 3 | 2011 | 662 | 0.580 |
Why?
|
Transposition of Great Vessels | 3 | 2010 | 590 | 0.540 |
Why?
|
Transplants | 1 | 2018 | 206 | 0.510 |
Why?
|
Kidney Transplantation | 2 | 2023 | 4217 | 0.510 |
Why?
|
Postoperative Complications | 12 | 2024 | 15637 | 0.510 |
Why?
|
Risk Factors | 35 | 2024 | 73809 | 0.500 |
Why?
|
Tacrolimus | 3 | 2023 | 733 | 0.480 |
Why?
|
Tomography, Emission-Computed | 7 | 2002 | 1121 | 0.460 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2011 | 1503 | 0.450 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2010 | 1240 | 0.450 |
Why?
|
Myocarditis | 2 | 2015 | 766 | 0.440 |
Why?
|
Male | 78 | 2024 | 358747 | 0.430 |
Why?
|
Humans | 113 | 2024 | 758406 | 0.430 |
Why?
|
Time Factors | 23 | 2021 | 39872 | 0.420 |
Why?
|
Female | 80 | 2024 | 390323 | 0.410 |
Why?
|
Vasodilator Agents | 6 | 2010 | 973 | 0.400 |
Why?
|
United States | 29 | 2021 | 72136 | 0.390 |
Why?
|
Survivors | 2 | 2019 | 2370 | 0.390 |
Why?
|
Kaplan-Meier Estimate | 11 | 2019 | 6493 | 0.390 |
Why?
|
Liver Transplantation | 1 | 2023 | 2325 | 0.380 |
Why?
|
Exercise | 5 | 2010 | 5788 | 0.380 |
Why?
|
Heart Failure, Systolic | 1 | 2012 | 135 | 0.380 |
Why?
|
Infant, Newborn | 21 | 2024 | 26183 | 0.370 |
Why?
|
ABO Blood-Group System | 2 | 2010 | 367 | 0.370 |
Why?
|
Ventricular Function | 1 | 2012 | 406 | 0.360 |
Why?
|
Postoperative Period | 6 | 2012 | 1812 | 0.340 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1797 | 0.330 |
Why?
|
Multivariate Analysis | 11 | 2015 | 12096 | 0.330 |
Why?
|
Hypoplastic Left Heart Syndrome | 2 | 2024 | 594 | 0.330 |
Why?
|
Pediatrics | 2 | 2021 | 3587 | 0.330 |
Why?
|
Enalapril | 1 | 2011 | 311 | 0.330 |
Why?
|
Histocompatibility | 1 | 2010 | 316 | 0.320 |
Why?
|
Treatment Outcome | 27 | 2021 | 64378 | 0.320 |
Why?
|
Patient Selection | 5 | 2019 | 4244 | 0.320 |
Why?
|
Propanolamines | 2 | 2006 | 162 | 0.310 |
Why?
|
Follow-Up Studies | 17 | 2020 | 39059 | 0.310 |
Why?
|
Carbazoles | 2 | 2006 | 220 | 0.290 |
Why?
|
Proportional Hazards Models | 10 | 2019 | 12440 | 0.290 |
Why?
|
Coronary Vessel Anomalies | 2 | 2002 | 308 | 0.290 |
Why?
|
Coronary Circulation | 5 | 2002 | 1561 | 0.280 |
Why?
|
Kidney Diseases | 2 | 2014 | 2083 | 0.280 |
Why?
|
Coronary Vessels | 5 | 2020 | 3072 | 0.270 |
Why?
|
Socioeconomic Factors | 5 | 2022 | 7818 | 0.270 |
Why?
|
Young Adult | 18 | 2021 | 58808 | 0.270 |
Why?
|
Models, Statistical | 4 | 2015 | 5070 | 0.260 |
Why?
|
Glomerular Filtration Rate | 1 | 2014 | 2154 | 0.260 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2019 | 272 | 0.260 |
Why?
|
Multicenter Studies as Topic | 2 | 2011 | 1705 | 0.260 |
Why?
|
Organ Size | 5 | 2022 | 2252 | 0.250 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2001 | 615 | 0.250 |
Why?
|
Fontan Procedure | 4 | 2017 | 791 | 0.250 |
Why?
|
Extracorporeal Membrane Oxygenation | 5 | 2019 | 1452 | 0.240 |
Why?
|
Databases, Factual | 5 | 2021 | 7980 | 0.240 |
Why?
|
Age Factors | 7 | 2021 | 18358 | 0.230 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3364 | 0.230 |
Why?
|
Coronary Artery Disease | 2 | 2022 | 6362 | 0.230 |
Why?
|
Lymphatic Irradiation | 1 | 2004 | 115 | 0.220 |
Why?
|
Giant Cells | 1 | 2004 | 185 | 0.220 |
Why?
|
Recovery of Function | 2 | 2011 | 2970 | 0.220 |
Why?
|
Boston | 5 | 2024 | 9304 | 0.210 |
Why?
|
Exercise Tolerance | 1 | 2008 | 830 | 0.210 |
Why?
|
Incidence | 11 | 2021 | 21272 | 0.210 |
Why?
|
Autonomic Nervous System | 1 | 2007 | 697 | 0.200 |
Why?
|
Atrial Flutter | 1 | 2004 | 252 | 0.200 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2457 | 0.200 |
Why?
|
Myocardial Ischemia | 2 | 2011 | 2108 | 0.200 |
Why?
|
Ventricular Remodeling | 1 | 2009 | 1256 | 0.200 |
Why?
|
Chi-Square Distribution | 4 | 2012 | 3425 | 0.200 |
Why?
|
Skeletal Muscle Ventricle | 1 | 2001 | 3 | 0.190 |
Why?
|
Hyperlipidemias | 1 | 2006 | 772 | 0.190 |
Why?
|
Predictive Value of Tests | 3 | 2013 | 15225 | 0.190 |
Why?
|
Echocardiography | 5 | 2020 | 4962 | 0.190 |
Why?
|
Adaptation, Physiological | 1 | 2008 | 1295 | 0.190 |
Why?
|
Antibodies | 2 | 2023 | 2420 | 0.190 |
Why?
|
Electric Countershock | 1 | 2004 | 533 | 0.190 |
Why?
|
Abnormalities, Multiple | 2 | 2019 | 1414 | 0.180 |
Why?
|
Adrenal Cortex Hormones | 1 | 2010 | 1870 | 0.180 |
Why?
|
Tunica Intima | 1 | 2003 | 459 | 0.180 |
Why?
|
Adult | 29 | 2022 | 219935 | 0.180 |
Why?
|
Transplantation, Homologous | 3 | 2023 | 4809 | 0.180 |
Why?
|
Nitrogen Radioisotopes | 3 | 2010 | 41 | 0.180 |
Why?
|
Lung | 4 | 2022 | 9985 | 0.180 |
Why?
|
Exercise Therapy | 1 | 2007 | 919 | 0.170 |
Why?
|
Annual Reports as Topic | 4 | 2019 | 36 | 0.170 |
Why?
|
Reoperation | 3 | 2019 | 4282 | 0.170 |
Why?
|
Isoantibodies | 1 | 2023 | 661 | 0.170 |
Why?
|
Resource Allocation | 2 | 2014 | 349 | 0.170 |
Why?
|
Vasodilation | 2 | 2003 | 960 | 0.170 |
Why?
|
Tricuspid Atresia | 1 | 2019 | 37 | 0.160 |
Why?
|
Growth | 1 | 2001 | 365 | 0.160 |
Why?
|
Health Status Disparities | 1 | 2011 | 1831 | 0.160 |
Why?
|
Adenosine | 5 | 2010 | 802 | 0.160 |
Why?
|
Body Size | 1 | 2022 | 462 | 0.160 |
Why?
|
Arteriosclerosis | 1 | 2003 | 1055 | 0.160 |
Why?
|
Carotid Arteries | 1 | 2003 | 939 | 0.160 |
Why?
|
Steroids | 1 | 2023 | 926 | 0.150 |
Why?
|
Leukemia | 1 | 2006 | 1519 | 0.150 |
Why?
|
Lymphoproliferative Disorders | 1 | 2022 | 533 | 0.150 |
Why?
|
Pulmonary Atresia | 1 | 2019 | 159 | 0.150 |
Why?
|
Digestive System Abnormalities | 1 | 2017 | 49 | 0.150 |
Why?
|
Cohort Studies | 11 | 2013 | 41256 | 0.150 |
Why?
|
Prognosis | 6 | 2022 | 29557 | 0.140 |
Why?
|
Biopsy | 3 | 2020 | 6768 | 0.140 |
Why?
|
Severity of Illness Index | 5 | 2021 | 15785 | 0.140 |
Why?
|
Coronary Angiography | 3 | 2022 | 4451 | 0.140 |
Why?
|
Cause of Death | 3 | 2014 | 3675 | 0.140 |
Why?
|
Myocardium | 4 | 2020 | 4690 | 0.140 |
Why?
|
Diet | 1 | 2014 | 8005 | 0.140 |
Why?
|
Residence Characteristics | 3 | 2010 | 2058 | 0.130 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 608 | 0.130 |
Why?
|
Propensity Score | 1 | 2023 | 1907 | 0.130 |
Why?
|
Ductus Arteriosus, Patent | 1 | 1997 | 218 | 0.120 |
Why?
|
Middle Aged | 15 | 2021 | 219568 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2022 | 1160 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2011 | 10146 | 0.110 |
Why?
|
Aged | 12 | 2021 | 168218 | 0.110 |
Why?
|
Bronchitis | 1 | 2014 | 196 | 0.110 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2013 | 321 | 0.110 |
Why?
|
Regional Blood Flow | 2 | 2010 | 1486 | 0.110 |
Why?
|
International Cooperation | 4 | 2019 | 1430 | 0.110 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9160 | 0.100 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2014 | 223 | 0.100 |
Why?
|
Parents | 1 | 2006 | 3548 | 0.100 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2012 | 61 | 0.100 |
Why?
|
Respiration, Artificial | 3 | 2014 | 2618 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2004 | 2244 | 0.100 |
Why?
|
Creatinine | 2 | 2014 | 1892 | 0.100 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2012 | 352 | 0.090 |
Why?
|
Hospitals, Pediatric | 2 | 2011 | 1854 | 0.090 |
Why?
|
Databases as Topic | 2 | 2011 | 472 | 0.090 |
Why?
|
Hemodynamics | 4 | 2013 | 4159 | 0.090 |
Why?
|
Prostheses and Implants | 1 | 1997 | 1270 | 0.090 |
Why?
|
Inpatients | 2 | 2012 | 2551 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2002 | 3339 | 0.080 |
Why?
|
Ventricular Function, Left | 2 | 2019 | 3858 | 0.080 |
Why?
|
Michigan | 2 | 2014 | 341 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2003 | 2540 | 0.080 |
Why?
|
Pulmonary Artery | 1 | 1998 | 1915 | 0.080 |
Why?
|
Palliative Care | 1 | 2024 | 3570 | 0.080 |
Why?
|
Hyperemia | 2 | 2001 | 221 | 0.080 |
Why?
|
Mass Screening | 1 | 2004 | 5427 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2003 | 3432 | 0.080 |
Why?
|
Dilatation, Pathologic | 1 | 2009 | 527 | 0.070 |
Why?
|
Sudden Infant Death | 1 | 2010 | 291 | 0.070 |
Why?
|
Pulse | 1 | 2007 | 218 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3216 | 0.070 |
Why?
|
Insurance, Health | 2 | 2009 | 2495 | 0.070 |
Why?
|
Ultrasonography | 3 | 2017 | 5952 | 0.070 |
Why?
|
Logistic Models | 6 | 2015 | 13276 | 0.070 |
Why?
|
Body Mass Index | 3 | 2010 | 12876 | 0.070 |
Why?
|
Blood Pressure | 2 | 2019 | 8451 | 0.070 |
Why?
|
Infant Mortality | 1 | 2011 | 757 | 0.060 |
Why?
|
Physical Endurance | 1 | 2008 | 362 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2004 | 5103 | 0.060 |
Why?
|
Surgical Procedures, Operative | 1 | 1997 | 1911 | 0.060 |
Why?
|
Patient Readmission | 1 | 2019 | 3261 | 0.060 |
Why?
|
Poisson Distribution | 1 | 2006 | 505 | 0.060 |
Why?
|
Treatment Failure | 1 | 2010 | 2640 | 0.060 |
Why?
|
Fetal Diseases | 1 | 2009 | 911 | 0.060 |
Why?
|
Cyclosporine | 1 | 2006 | 777 | 0.060 |
Why?
|
HLA Antigens | 2 | 2023 | 1368 | 0.060 |
Why?
|
Antineoplastic Agents | 1 | 2006 | 13591 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2011 | 2432 | 0.050 |
Why?
|
Ventricular Dysfunction | 1 | 2004 | 144 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2011 | 1780 | 0.050 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2012 | 1309 | 0.050 |
Why?
|
Patient Compliance | 1 | 2013 | 2685 | 0.050 |
Why?
|
Health Resources | 1 | 2009 | 931 | 0.050 |
Why?
|
Algorithms | 2 | 2014 | 13961 | 0.050 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 2 | 1999 | 537 | 0.050 |
Why?
|
Heart Block | 1 | 2004 | 392 | 0.050 |
Why?
|
Minority Groups | 1 | 2009 | 1206 | 0.050 |
Why?
|
Histocompatibility Testing | 1 | 2024 | 717 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2012 | 6821 | 0.050 |
Why?
|
Liver | 1 | 2017 | 7502 | 0.050 |
Why?
|
Norwood Procedures | 1 | 2024 | 192 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4839 | 0.050 |
Why?
|
Disease Progression | 2 | 2013 | 13468 | 0.050 |
Why?
|
Echocardiography, Stress | 1 | 2022 | 134 | 0.050 |
Why?
|
Anaerobic Threshold | 1 | 2001 | 51 | 0.050 |
Why?
|
Brachial Artery | 1 | 2003 | 365 | 0.050 |
Why?
|
Antigens, CD20 | 1 | 2022 | 201 | 0.050 |
Why?
|
Income | 1 | 2010 | 1872 | 0.050 |
Why?
|
Sampling Studies | 1 | 2002 | 614 | 0.050 |
Why?
|
Microspheres | 2 | 2001 | 787 | 0.050 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2006 | 574 | 0.050 |
Why?
|
Myocardial Stunning | 1 | 2000 | 66 | 0.040 |
Why?
|
Perfusion | 2 | 2002 | 1374 | 0.040 |
Why?
|
Reference Values | 1 | 2007 | 4919 | 0.040 |
Why?
|
Medicaid | 2 | 2013 | 2807 | 0.040 |
Why?
|
Linear Models | 1 | 2010 | 5862 | 0.040 |
Why?
|
Cholesterol, HDL | 1 | 2006 | 1808 | 0.040 |
Why?
|
Radioisotopes | 1 | 2001 | 495 | 0.040 |
Why?
|
Neutropenia | 1 | 2005 | 884 | 0.040 |
Why?
|
Dogs | 2 | 2001 | 3840 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2002 | 743 | 0.040 |
Why?
|
Acute Disease | 2 | 2006 | 7225 | 0.040 |
Why?
|
Triglycerides | 1 | 2006 | 2451 | 0.040 |
Why?
|
Heart Atria | 1 | 2004 | 1344 | 0.040 |
Why?
|
Echocardiography, Transesophageal | 1 | 2004 | 1088 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10748 | 0.040 |
Why?
|
Cholesterol | 1 | 2006 | 2902 | 0.040 |
Why?
|
Stroke Volume | 1 | 2011 | 5460 | 0.040 |
Why?
|
Respiratory Mechanics | 1 | 2001 | 699 | 0.040 |
Why?
|
Ammonia | 1 | 1998 | 236 | 0.040 |
Why?
|
Cholesterol, LDL | 1 | 2006 | 2374 | 0.040 |
Why?
|
Thrombocytopenia | 1 | 2005 | 1171 | 0.030 |
Why?
|
Electrocardiography | 1 | 2010 | 6363 | 0.030 |
Why?
|
Prospective Studies | 2 | 2012 | 54137 | 0.030 |
Why?
|
Muscle Contraction | 1 | 2001 | 1197 | 0.030 |
Why?
|
Kidney | 1 | 2011 | 7016 | 0.030 |
Why?
|
Age of Onset | 1 | 2003 | 3298 | 0.030 |
Why?
|
Child Development | 1 | 2007 | 2285 | 0.030 |
Why?
|
Cardiac Output | 1 | 1998 | 837 | 0.030 |
Why?
|
Recurrence | 2 | 2004 | 8426 | 0.030 |
Why?
|
Aortic Valve Insufficiency | 1 | 1999 | 578 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2009 | 3992 | 0.030 |
Why?
|
Piperazines | 1 | 2004 | 2511 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2010 | 6457 | 0.030 |
Why?
|
Hypertension, Pulmonary | 1 | 2004 | 1564 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2003 | 2060 | 0.030 |
Why?
|
Chest Tubes | 1 | 2014 | 152 | 0.030 |
Why?
|
Chylothorax | 1 | 2014 | 83 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 1998 | 1146 | 0.030 |
Why?
|
Prevalence | 2 | 2009 | 15651 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3563 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2007 | 4902 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2004 | 2747 | 0.030 |
Why?
|
Ascites | 1 | 2014 | 338 | 0.030 |
Why?
|
Radiopharmaceuticals | 2 | 2000 | 2634 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2009 | 5404 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 3227 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2007 | 14490 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2001 | 5199 | 0.020 |
Why?
|
Odds Ratio | 2 | 2014 | 9650 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 25956 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6354 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2284 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2013 | 664 | 0.020 |
Why?
|
Anticoagulants | 1 | 2004 | 4777 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2013 | 58683 | 0.020 |
Why?
|
Drainage | 1 | 2014 | 1161 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2014 | 22029 | 0.020 |
Why?
|
Hospitalization | 2 | 2006 | 10652 | 0.020 |
Why?
|
Preoperative Period | 1 | 2009 | 553 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14641 | 0.020 |
Why?
|
Vascular Resistance | 2 | 2002 | 930 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2011 | 809 | 0.020 |
Why?
|
Herpesvirus 6, Human | 1 | 2005 | 97 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 1997 | 5484 | 0.010 |
Why?
|
Health Care Costs | 1 | 1997 | 3245 | 0.010 |
Why?
|
Length of Stay | 1 | 1997 | 6439 | 0.010 |
Why?
|
Sulfones | 1 | 2004 | 446 | 0.010 |
Why?
|
Purines | 1 | 2004 | 605 | 0.010 |
Why?
|
Ultrasonography, Prenatal | 1 | 2009 | 1745 | 0.010 |
Why?
|
Carbon Radioisotopes | 1 | 2000 | 557 | 0.010 |
Why?
|
Myocardial Reperfusion | 1 | 2000 | 337 | 0.010 |
Why?
|
Patient Discharge | 1 | 2011 | 3433 | 0.010 |
Why?
|
Poverty | 1 | 2009 | 2692 | 0.010 |
Why?
|
Administration, Oral | 1 | 2004 | 3991 | 0.010 |
Why?
|
Defibrillators, Implantable | 1 | 2004 | 1487 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 2000 | 1516 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 2004 | 2248 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1999 | 2210 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2005 | 3142 | 0.010 |
Why?
|
Animals | 2 | 2001 | 167768 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2000 | 2004 | 0.010 |
Why?
|
Hypertension | 1 | 1991 | 8499 | 0.010 |
Why?
|
Chronic Disease | 1 | 2004 | 9267 | 0.010 |
Why?
|
Glucose | 1 | 2000 | 4336 | 0.000 |
Why?
|
Pregnancy | 1 | 2009 | 29742 | 0.000 |
Why?
|
India | 1 | 1991 | 2329 | 0.000 |
Why?
|